PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems
|
By LabMedica International staff writers Posted on 18 May 2021 |
|
Illustration
PerkinElmer, Inc. (Waltham, MA; USA) and Immunodiagnostic Systems Holdings PLC (IDS; Boldon, Tyne and Wear, UK) have reached an agreement whereby PerkinElmer will acquire IDS for approximately USD 155 million.
IDS develops, manufactures, and markets innovative immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. IDS’s immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields. PerkinElmer's comprehensive global diagnostics portfolio includes solutions focused on: reproductive health; autoimmune, infectious disease and allergy testing; gene analyses; and genomics offerings for oncology and other molecular tests through its wide range of instruments, reagents, assay platforms and software offerings.
Through this acquisition, PerkinElmer will be able to grow its overall Diagnostics business and specifically its immunodiagnostics segment. Moreover, the deal will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’ best-in-class chemiluminescence products in endocrinology, autoimmunity and infectious diseases to better serve customers around the world. IDS’s portfolio and expertise will seamlessly integrate within EUROIMMUN, a PerkinElmer company since 2017. EUROIMMUN is a global leader in autoimmune testing and an emerging force in infectious disease, allergy and molecular genetic testing.
“This proposed transaction is highly valuable for both parties as the respective product lines are to a large extent complementary,” said Wolfgang Schlumberger, CEO of EUROIMMUN. “The cooperation of our global distribution channels, the expansion of the immunoassay portfolio in closely related indication fields and IDS's fully automated random access chemiluminescence platform strengthens our presence in immunodiagnostics. Our customers will benefit from a broader range of assays and laboratory diagnostic workflows. We are excited about these new opportunities and we look forward to welcoming Immunodiagnostic Systems into the PerkinElmer family following the completion of the transaction.”
Related Links:
PerkinElmer, Inc.
Immunodiagnostic Systems Holdings PLC (IDS)
IDS develops, manufactures, and markets innovative immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. IDS’s immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields. PerkinElmer's comprehensive global diagnostics portfolio includes solutions focused on: reproductive health; autoimmune, infectious disease and allergy testing; gene analyses; and genomics offerings for oncology and other molecular tests through its wide range of instruments, reagents, assay platforms and software offerings.
Through this acquisition, PerkinElmer will be able to grow its overall Diagnostics business and specifically its immunodiagnostics segment. Moreover, the deal will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’ best-in-class chemiluminescence products in endocrinology, autoimmunity and infectious diseases to better serve customers around the world. IDS’s portfolio and expertise will seamlessly integrate within EUROIMMUN, a PerkinElmer company since 2017. EUROIMMUN is a global leader in autoimmune testing and an emerging force in infectious disease, allergy and molecular genetic testing.
“This proposed transaction is highly valuable for both parties as the respective product lines are to a large extent complementary,” said Wolfgang Schlumberger, CEO of EUROIMMUN. “The cooperation of our global distribution channels, the expansion of the immunoassay portfolio in closely related indication fields and IDS's fully automated random access chemiluminescence platform strengthens our presence in immunodiagnostics. Our customers will benefit from a broader range of assays and laboratory diagnostic workflows. We are excited about these new opportunities and we look forward to welcoming Immunodiagnostic Systems into the PerkinElmer family following the completion of the transaction.”
Related Links:
PerkinElmer, Inc.
Immunodiagnostic Systems Holdings PLC (IDS)
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Blood Glucose Test Strip
AutoSense Test
Latest Industry News
- Werfen and VolitionRx Partner to Advance Diagnostic Testing for Antiphospholipid Syndrome
- Siemens Healthineers and Carna Health Partner to Advance Kidney Care Innovation
- Vircell Launches New Website for Molecular Control Products
- Tempus AI Acquires Digital Pathology Company Paige
- New Manual to Help Clinicians Better Diagnose and Treat Infection-Associated Chronic Illness
- WHO Releases Updated Guidance on Tuberculosis Diagnosis
- Pioneering Collaboration to Transform Pediatric Cancer Diagnostics and Research
- Bio-Techne Divests Exosome Diagnostics to Reposition Product Portfolio
- New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis
- IFCC WorldLab 2026 To Be Held in India on October 25-29
- PHASE Scientific and Lumos Diagnostics Partner on Rapid POC Test for Bacterial Respiratory Infection
- QuidelOrtho and BÜHLMANN Collaborate on Gastrointestinal Biomarker Tests
- BD Biosciences & Diagnostic Solutions to Merge with Waters
- 2025 COMPAMED Innovation Forum Highlights Pioneering Work in Cancer Diagnostics
- Quanterix Completes Acquisition of Akoya Biosciences
- Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more
Molecular Diagnostics
view channel
Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more
Single Cell RNA Sequencing Could Enable Non-Invasive Blood Disorder Diagnosis
Hematologic disorders are often diagnosed using painful, invasive, and expensive bone marrow aspiration or biopsy procedures. These approaches limit patient compliance and broader utility, leaving a need... Read more
Blood Test Identifies HPV-Associated Head and Neck Cancers 10 Years Before Symptoms
Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, and cases are rising each year. Unlike cervical cancers linked to HPV, there is currently no screening test for... Read more
Hematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more
Immunology
view channel
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis
Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more
Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients
Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read more
Technology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
